By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Crypto.com and AEG on Their Historic Deal to Rename the Staples Center
Beginning Christmas Day, the home of the Los Angeles Lakers, Clippers, Kings, and Sparks, the Staples Center, will go by the name Crypto.com Arena after a massive $700 million deal with AEG. Steven Kalifowitz, the chief marketing officer at Crypto.com, and Todd Goldstein, the chief revenue officer at AEG, joined Cheddar to talk about the historic changeover in naming rights and what other changes that fans entering the arena might expect.
Qualcomm Extends BMW Partnership to Develop Automated Driving Tech
Earlier this week, Qualcomm announced an extension of its partnership with BMW as it moves to help build the technology for automated driving. Nakul Duggal, general manager at Qualcomm, joined Cheddar to provide some background on the collaboration and how the company has been able to navigate the global chip shortage amid the pandemic. "We have invested in advance, in very specific packaging capacity and technology, with our suppliers so that we actually have the capacity available to be able to service that demand," Duggal said.
Survey Shows Small Business Owners See Less Stigma Around Loans Since COVID
Small businesses are seeing loans in a new light thanks to the pandemic, according to a survey from PayPal and Wakefield research. The study found that the stigma surrounding accepting loans has largely been removed among a majority of small business owners who realize they are not a sign of a struggling business, but a way to stay competitive. Bernardo Martinez, VP of global merchant lending at PayPal, joined Cheddar to discuss the results of the survey and provide tips to owners looking to grow their businesses.
Adapting Business Technology to an Unpredictable World
No one is ever fully "ready" for the future. However, the past two years have clearly shown us that some businesses can be better prepared for the future than others. Shelly Kramer, Founding Partner & Lead Analyst of Futurum Research, joins Cheddar News to discuss how businesses of all sizes can stay agile enough to adapt to whatever the future may bring.
Boosters For All, Diplomatic Boycott of Beijing Olympics & The Perfect Hug
Jill is joined by “Friend of the Pod” Mosheh Oinounou to talk booster shots, and whether “fully vaccinated” will eventually mean three shots, not two. Plus, the latest on the Kyle Rittenhouse trial. And the research is in: we know now the perfect way to hug. Also, Jill and Mosheh debate whether Airpods are passé.
Load More